Patent applications and USPTO patent grants for Rigenerand S.R.L..The latest application filed is for "method for the production of bi-functional cells to treat neoplasia".
Patent | Date |
---|---|
Method For The Production Of Bi-functional Cells To Treat Neoplasia App 20210300990 - Golinelli; Giulia ;   et al. | 2021-09-30 |
Method To Produce Conditionally Apoptotic Cells App 20210214689 - Rossignoli; Filippo ;   et al. | 2021-07-15 |
Method For The Production Of Cellular Particulate With Antitumor Activity App 20210054339 - Rossignoli; Filippo ;   et al. | 2021-02-25 |
Device, Kit And Method For Three-dimensional Cell Culture App 20200407673 - DOMINICI; Massimo ;   et al. | 2020-12-31 |
Device for cell culture Grant 9,057,047 - Conte , et al. June 16, 2 | 2015-06-16 |
Device for cell culture App 20110129913 - Conte; Pierfranco ;   et al. | 2011-06-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.